��������

Laura Wahlberg is an accomplished finance executive with extensive experience in the biotechnology sector. Currently serving as Vice President of Finance at Photys Therapeutics since November 2022, Wahlberg has previously held similar roles at Chroma Medicine and C4 Therapeutics, Inc., where responsibilities included overseeing financial strategy and operations. Wahlberg has a robust background as Director of Finance at various organizations, including Neurotech Pharmaceuticals, Point Therapeutics, and as Controller at ImmuLogic Pharmaceuticals. An independent financial consultant from 2011 to 2013, Wahlberg provided essential financial advisory services to start-up biotech firms. Educational credentials include an MBA in Finance from Bentley University and a Bachelor's in Management - Accounting from UMass Boston.